ScreenerHero

SSII SS Innovations International, Inc.

NAS · US · Healthcare · Medical Devices · ssinnovations.com
2.740USD-0.72%Mkt Cap: 548.00M $P/E: —

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE)…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$171.97BUSDP/E 31.8
MDT
Medtronic plc
$109.38BUSDP/E 21.0
SYK
Stryker Corporation
$105.64BUSDP/E 28.5
BSX
Boston Scientific Corporation
$60.26BUSDP/E 16.8
EW
Edwards Lifesciences Corporation
$49.39BUSDP/E 51.1
SHL
Siemens Healthineers AG
$46.91BUSDP/E 19.6
DXCM
DexCom, Inc.
$31.81BUSDP/E 33.5
GEHC
GE HealthCare Technologies Inc.
$29.42BUSDP/E 14.9
PHIA
Koninklijke Philips N.V.
$22.87BUSDP/E 18.7
PHG
Koninklijke Philips N.V.
$23.55BUSDP/E 18.0
STE
STERIS plc
$20.44BUSDP/E 25.6
SOON
Sonova Holding AG
$17.11BUSDP/E 28.0
ZBH
Zimmer Biomet Holdings, Inc.
$16.88BUSDP/E 21.5
PEN
Penumbra, Inc.
$12.46BUSDP/E 77.7
SNN
Smith & Nephew plc
$11.25BUSDP/E 18.3
DEMANT
Demant A/S
$9.87BUSDP/E 28.0
GKOS
Glaukos Corporation
$10.16BUSD
TXG
10x Genomics, Inc.
$9.92BUSD
GMED
Globus Medical, Inc.
$9.90BUSDP/E 18.9
BIO
Bio-Rad Laboratories, Inc.
$9.85BUSDP/E 46.6

Key Statistics

Company
Market Cap548.00M USD
Enterprise Value557.29M USD
Revenue (TTM)52.40M USD
Gross Profit19.54M USD
Net Income (TTM)-12.13M USD
Revenue/Share0.27 USD
Last Price2.740 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees483
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-46.00
PEG—
EV/EBITDA-77.50
EV/Revenue10.63
P/S10.53
P/B10.34
EPS (TTM)-0.06
EPS (Forward)-0.06
52W Range
2.6202% of range10.00
52W High10.00 USD
52W Low2.620 USD
Profitability
Gross Margin46.00%
Oper. Margin-16.29%
EBITDA Margin-13.72%
Profit Margin-28.55%
ROE-31.73%
ROA-16.34%
Growth
Revenue Growth39.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.54M USD
CapEx (TTM)3.66M USD
FCF Margin-7.44%
FCF Yield-0.71%
Net Debt4.23M USD
Net Debt/EBITDA-0.59
Balance Sheet
Debt/Equity0.38
Current Ratio2.24
Quick Ratio1.19
Book Value/Sh0.27 USD
Cash/Share0.07 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)7.000 USD
Upside (mean)+155.5%
Target Range7.000 USD – 7.000 USD
# Analysts1
Ownership
Shares Out.200.00M
Float40.62M
Insiders80.11%
Institutions0.85%
Short Interest
Short Ratio1.2d
Short % Float0.11%
Short % Out.0.03%
Shares Short59.66K
Short (prev mo.)67.92K
Technical
SMA 503.449 (-20.6%)
SMA 2004.178 (-34.4%)
Beta0.73
S&P 52W Chg15.78%
Avg Vol (30d)62.11K
Avg Vol (10d)78.14K
Technical Indicators
RSI (14)30.9
MACD-0.2081
MACD Signal-0.1871
MACD Hist.-0.0210
BB Upper3.561 USD
BB Middle3.061 USD
BB Lower2.560 USD
BB Width32.69%
ATR (14)0.1998 USD
Vol Ratio (20d)0.29x